Literature DB >> 8493102

Thermal stability of DNA adducts induced by cyanomorpholinoadriamycin in vitro.

C Cullinane1, D R Phillips.   

Abstract

The Adriamycin derivative, cyanomorpholinoadriamycin (CMA) was reacted with DNA in vitro to form apparent interstrand crosslinks. The extent of interstrand crosslink formation was monitored by a gel electrophoresis assay and maximal crosslinking of DNA was observed within 1 hr with 5 microM of drug. The interstrand crosslinks were heat labile, with a midpoint melting temperature of 70 degrees C (10 min exposure to heat) in 45% formamide. When CMA-induced adducts were detected as blockages of lambda-exonuclease, 12 blockage sites were observed with 8 being prior to 5'-GG sequences, one prior to 5'-CC, one prior to 5'-GC and 2 at unresolved combinations of these sequences. These exonuclease-detected blockages reveal the same sites of CMA-induced crosslinking as detected by in vitro transcription footprinting and primer-extension blockages on single strand DNA, where the blockages at 5'-GG and 5'-CC were identified as sites of intrastrand crosslinking and the 5'-GC blockage as a probable site of interstrand crosslinking. The thermal stability of both types of crosslink (10 min exposure to heat) ranged from 63-70 degrees C at individual sites. High levels of adduct were detected with poly (dG-dC) but not with poly (dI-dC). These results suggest adduct formation involving an aminal linkage between the 3 position of the morpholino moiety and N2 of guanine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8493102      PMCID: PMC309425          DOI: 10.1093/nar/21.8.1857

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

Review 1.  A new insight into adriamycin-induced cardiotoxicity.

Authors:  L X Fu; F Waagstein; A Hjalmarson
Journal:  Int J Cardiol       Date:  1990-10       Impact factor: 4.164

2.  Transcriptional analysis of multisite drug-DNA dissociation kinetics: delayed termination of transcription by actinomycin D.

Authors:  R J White; D R Phillips
Journal:  Biochemistry       Date:  1988-12-27       Impact factor: 3.162

3.  Elucidation of the DNA sequence preferences of daunomycin.

Authors:  A Skorobogaty; R J White; D R Phillips; J A Reiss
Journal:  Drug Des Deliv       Date:  1988-07

4.  DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs.

Authors:  R P Hertzberg; S M Hecht; V L Reynolds; I J Molineux; L H Hurley
Journal:  Biochemistry       Date:  1986-03-25       Impact factor: 3.162

5.  Lesion selectivity in blockage of lambda exonuclease by DNA damage.

Authors:  W B Mattes
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

6.  Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin.

Authors:  M I Jesson; J B Johnston; E Robotham; A Begleiter
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

7.  Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.

Authors:  K Wassermann; J Markovits; C Jaxel; G Capranico; K W Kohn; Y Pommier
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

8.  Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.

Authors:  K Wassermann; L A Zwelling; T D Mullins; L E Silberman; B S Andersson; M Bakic; E M Acton; R A Newman
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

9.  Mechanistic aspects of DNA damage by morpholinyl and cyanomorpholinyl anthracyclines.

Authors:  J Westendorf; M Aydin; G Groth; O Weller; H Marquardt
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

Review 10.  Free radicals in anticancer drug pharmacology.

Authors:  B K Sinha
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

View more
  4 in total

1.  An in vitro transcription assay for probing drug-DNA interactions at individual drug sites.

Authors:  D R Phillips; C M Cullinane; D M Crothers
Journal:  Mol Biotechnol       Date:  1998-08       Impact factor: 2.695

2.  Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts.

Authors:  B S Parker; S M Cutts; C Cullinane; D R Phillips
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

3.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

4.  High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.

Authors:  A Nagy; P Armatis; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.